Mark Eisner - 21 Feb 2026 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role: Director
Signature: /s/ Kim Davis, Attorney-in-Fact
Issuer symbol: ZURA
Transactions as of: 21 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 24 Feb 2026, 21:14:02 UTC
Previous filing: 17 Jul 2025
Next filing: 24 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Eisner Mark	Director	C/O ZURA BIO LIMITED, 1489 W. WARM SPRINGS RD. #110, HENDERSON	/s/ Kim Davis, Attorney-in-Fact	24 Feb 2026	0001834161

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZURA	Share Option (Right to Buy)	Award	$0	+37,812		$0.000000	37,812	21 Feb 2026	Class A Ordinary Shares	37,812	$6.53	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option vests in twelve substantially equal monthly installments over a one-year period measured from February 21, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date.